"Nanomedicine, from research to patient and industry"
The application of nanotechnology to medicine and health, named Nanomedicine, has great potential to improve public welfare and enhance
economic growth, thus improving the quality of life of people in Europe and around the globe. Progress in Nanomedicine implies multidisciplinary
research between academics, health/clinical teams and research teams of the biomedical and/or pharmaceutical industries, attainable through trans-national collaboration. There is a need to bridge the gap between the developments in basic nanotechnology research at the academic level and the application of such new technologies to the benefit of patients.
This requires the shortening of the time from research result to the market and to clinical use. Since national programmes may not be sufficient to tackle these challenges, a Pan- European approach, such as EuroNanoMed, is required to support transnational, multidisciplinary RTD projects.
The EuroNanoMed ERA-Net initiative aims at launching specific Calls for Proposals to support trans-national collaborative RTD projects between academic laboratories, companies, especially SME's, and clinical/public health actors, in the field of Nanomedicine, using a bottom up approach EuroNanoMed has gathered the support of an impressive number of 24 governments, ministries and agencies from 15 EU Member States and Associate countries, as well as 3 regions in Europe. The total budget dedicated to the EuroNanoMed calls for proposals represents a unique commitment.
EuroNanoMed is launched its 3rd Joint Call for funding of transnational innovative research projects in Nanomedicine. This call will enable scientists from European and associated countries to establish collaborative research consortia spanning multiple disciplines.
Participating Member states and Regions:
Basque region (Spain), France, Germany, Iceland, Israel, Latvia, Lithuania, Poland, Romania, Spain, Switzerland, Turkey, Walloon region (Belgium), Veneto region (Italy).
The thematic priorities of the call focus on the strategic research priorities of the European technology platform “Nanomedicine":
- Regenerative medicine
- Diagnostics
- Targeted delivery systems
Deadline for submission: April 15th 2011 at 17:00:00 (Brussels local time)
For futher information follow the link to the EuroNanoMed website.